Overview of the policies, procedures, and protocols developed by an ADAP and Part C clinic to establish access to antiretrovirals, including long-acting cabotegravir/rilpivirine.
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approva
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Implementation of innovations for End the HIV Epidemic (EHE) efforts requires innovative research/community collaborations.
Review of the terminology of addiction, opioid use, and MAT, in order to enhance staff understanding of how buprenorphine treatment fits into the larger treatment picture and improve their health literacy on the subject. Chapter in the curriculum, Integration of Buprenorphine into HIV Primary Care Settings.